Anuh Pharma Balance Sheet Annual

Trade

BSE: 506260 | NSE: - | ISIN: INE489G01022 | Sector: Biotechnology & Drugs

199.75 +4.85 (2.49%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	7.20	1.93	3.80	2.20
Cash Equivalents	2.47	3.05	11.00	0.00
Short Term Investments	55.44	52.65	22.47	28.71
Cashand Short Term Investments	65.11	57.63	37.26	30.91
Accounts Receivable- Trade Net	189.95	171.31	135.89	106.96
Total Receivables Net	190.57	171.82	140.46	124.17
Total Inventory	75.40	73.61	79.99	81.55
Other Current Assets Total	5.12	3.99	0.49	0.66
Total Current Assets	336.20	307.61	258.69	237.73
Property/ Plant/ Equipment Total- Net	49.24	52.68	61.34	71.18
Intangibles Net	0.16	0.13	0.18	0.24
Long Term Investments	41.71	39.68	21.21	20.37
Note Receivable- Long Term	17.95	3.04	1.12	3.12
Other Long Term Assets Total	0.42	1.84	4.64	-
Total Assets	445.68	404.98	347.17	332.64
Accounts Payable	140.50	152.77	121.57	120.02
Notes Payable/ Short Term Debt	2.01	0.00	3.11	13.60
Current Portof LT Debt/ Capital Leases	0.29	0.07	0.21	0.08
Other Currentliabilities Total	9.89	8.09	5.74	5.54
Total Current Liabilities	152.69	161.34	130.91	139.47
Capital Lease Obligations	0.39	0.84	0.91	0.00
Total Long Term Debt	0.39	0.84	0.91	0.00
Total Debt	2.69	0.91	4.22	13.68
Other Liabilities Total	1.38	1.58	1.54	1.51
Total Liabilities	154.46	163.76	133.40	142.00
Common Stock Total	25.06	25.06	25.06	25.06
Retained Earnings( Accumulated Deficit)	266.16	216.07	188.66	165.62
Total Equity	291.22	241.22	213.77	190.64
Total Liabilities Shareholders' Equity	445.68	404.98	347.17	332.64
Total Common Shares Outstanding	5.01	5.01	5.01	5.01
Tangible Book Valueper Share Common Eq	58.08	48.11	42.62	38.00
Prepaid Expenses	-	0.57	0.48	0.44
Property/ Plant/ Equipment Total- Gross	-	99.40	98.77	64.27
Accumulated Depreciation Total	-	-46.72	-37.43	-19.24
Accrued Expenses	-	0.41	0.28	0.24
Deferred Income Tax	-	0.00	0.05	1.01
Other Equity Total	-	0.09	0.06	-0.03